Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DR26FA4LR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,638
Award facts
- Contract value 100% obligated
- $25,637.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $25,637.70 delivery order to Amerisourcebergen Drug Corp on June 23, 2026, for Ocrevus 300 mg/10 ml vials.
Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of July 15, 2026. The source does not identify the parent IDC vehicle by name; however, Amerisourcebergen Drug Corp holds standing indefinite delivery contracts with DLA Troop Support Medical supporting pharmaceutical distribution to military healthcare systems globally.
Quick answers
Who was awarded contract SPE2DR26FA4LR?
SPE2DR26FA4LR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 23, 2026.
How much is contract SPE2DR26FA4LR worth?
The government has obligated $25,638 on SPE2DR26FA4LR.
Is contract SPE2DR26FA4LR an order under another contract?
Yes. SPE2DR26FA4LR is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA4LR competed?
The extent of competition for SPE2DR26FA4LR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award